High expression of VPAC1 receptors (104/cell) in prostate cancer has been confirmed by Nerli et al.25, 26Fütterer et al.27imaged prostate cancers in humans with >97% sensitivity, using a Cu‐64 labelled VPAC1 specific peptide designed in their laboratories. Here, VIPR1 is linked to prostate carcinoma.